Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMATI AIM VCT PLC Director's Dealing 2018

May 22, 2018

4808_dirs_2018-05-22_8e07cb08-405e-4fbe-b978-57f851adbb46.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9163O

Amati AIM VCT PLC

22 May 2018

Transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

MS JULIA HENDERSON

2

Reason for the notification

a)

Position/status

DIRECTOR

b)

Initial notification /Amendment

INITIAL NOTIFICATION

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

AMATI AIM VCT PLC

b)

LEI

213800HAEDBBK9RWCD25

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

ORDINARY SHARES OF 5P EACH

ISIN: GB00B641BB82

b)

Nature of the transaction

SHARES ALLOTTED UNDER THE OFFER.

c)

Price(s) and volume(s)

Price(s) Volume(s)
183.83P PER SHARE 2,719 ORDINARY SHARES OF 5P EACH

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

21/05/2018

f)

Place of the transaction

LONDON STOCK EXCHANGE, MAIN MARKET (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHSESFDEFASEII